These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18248830)

  • 1. Structural and clinical implications of amino acid substitutions in N-acetylgalactosamine-4-sulfatase: insight into mucopolysaccharidosis type VI.
    Saito S; Ohno K; Sugawara K; Sakuraba H
    Mol Genet Metab; 2008 Apr; 93(4):419-25. PubMed ID: 18248830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase.
    Litjens T; Hopwood JJ
    Hum Mutat; 2001 Oct; 18(4):282-95. PubMed ID: 11668612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): a Y210C mutation causes either altered protein handling or altered protein function of N-acetylgalactosamine 4-sulfatase at multiple points in the vacuolar network.
    Bradford TM; Litjens T; Parkinson EJ; Hopwood JJ; Brooks DA
    Biochemistry; 2002 Apr; 41(15):4962-71. PubMed ID: 11939792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Database of the clinical phenotypes, genotypes and mutant arylsulfatase B structures in mucopolysaccharidosis type VI.
    Saito S; Ohno K; Sekijima M; Suzuki T; Sakuraba H
    J Hum Genet; 2012 Apr; 57(4):280-2. PubMed ID: 22336888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients.
    Litjens T; Brooks DA; Peters C; Gibson GJ; Hopwood JJ
    Am J Hum Genet; 1996 Jun; 58(6):1127-34. PubMed ID: 8651289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucopolysaccharidosis type VI: Report of two Taiwanese patients and identification of one novel mutation.
    Yang CF; Wu JY; Lin SP; Tsai FJ
    J Formos Med Assoc; 2001 Dec; 100(12):820-3. PubMed ID: 11802522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and clinical implications of amino acid substitutions in α-L-iduronidase: insight into the basis of mucopolysaccharidosis type I.
    Saito S; Ohno K; Maita N; Sakuraba H
    Mol Genet Metab; 2014 Feb; 111(2):107-12. PubMed ID: 24480078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural study on mutant alpha-L-iduronidases: insight into mucopolysaccharidosis type I.
    Sugawara K; Saito S; Ohno K; Okuyama T; Sakuraba H
    J Hum Genet; 2008; 53(5):467-474. PubMed ID: 18340403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Basis of Mucopolysaccharidosis Type II and Construction of a Database of Mutant Iduronate 2-Sulfatases.
    Saito S; Ohno K; Okuyama T; Sakuraba H
    PLoS One; 2016; 11(10):e0163964. PubMed ID: 27695081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum.
    Brooks DA; Gibson GJ; Karageorgos L; Hein LK; Robertson EF; Hopwood JJ
    Mol Genet Metab; 2005 Jul; 85(3):236-8. PubMed ID: 15979036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylgalactosamine-4-sulfatase: identification of four new mutations within the conserved sulfatase region causing mucopolysaccharidosis type VI.
    Simonaro CM; Schuchman EH
    Biochim Biophys Acta; 1995 Dec; 1272(3):129-32. PubMed ID: 8541342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) due to homozygosity for the p.Y210C mutation in the ARSB gene.
    Gottwald I; Hughes J; Stewart F; Tylee K; Church H; Jones SA
    Mol Genet Metab; 2011 Jul; 103(3):300-2. PubMed ID: 21514195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of mucopolysaccharidosis type VI in Poland, Belarus, Lithuania and Estonia.
    Jurecka A; Piotrowska E; Cimbalistiene L; Gusina N; Sobczyńska A; Czartoryska B; Czerska K; Õunap K; Węgrzyn G; Tylki-Szymańska A
    Mol Genet Metab; 2012 Feb; 105(2):237-43. PubMed ID: 22133300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Mutations, Including a Large Deletion in the ARSB Gene, Causing Mucopolysaccharidosis Type VI.
    Ittiwut C; Boonbuamas S; Srichomthong C; Ittiwut R; Suphapeetiporn K; Shotelersuk V
    Genet Test Mol Biomarkers; 2017 Jan; 21(1):58-62. PubMed ID: 27797586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI].
    Zheng J; Huang Y; Zhao X; Sheng H; Cheng J; Zhou Z; Li X; Mao X; Liu L
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):403-8. PubMed ID: 25190157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feline mucopolysaccharidosis type VI: correction of glycosaminoglycan storage in myoblasts by retrovirus-mediated transfer of the feline N-acetylgalactosamine 4-sulfatase gene.
    Yogalingam G; Bielicki J; Hopwood JJ; Anson DS
    DNA Cell Biol; 1997 Oct; 16(10):1189-94. PubMed ID: 9364929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucopolysaccharidosis type VI: case report with first neonatal presentation with ascites fetalis and rapidly progressive cardiac manifestation.
    Honjo RS; Vaca ECN; Leal GN; Abellan DM; Ikari NM; Jatene MB; Martins AM; Kim CA
    BMC Med Genet; 2020 Feb; 21(1):37. PubMed ID: 32075597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of 105 mucopolysaccharidosis type VI patients.
    Karageorgos L; Brooks DA; Pollard A; Melville EL; Hein LK; Clements PR; Ketteridge D; Swiedler SJ; Beck M; Giugliani R; Harmatz P; Wraith JE; Guffon N; Leão Teles E; Sá Miranda MC; Hopwood JJ
    Hum Mutat; 2007 Sep; 28(9):897-903. PubMed ID: 17458871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literature.
    Jurecka A; Zakharova E; Malinova V; Voskoboeva E; Tylki-Szymańska A
    Clin Rheumatol; 2014 May; 33(5):725-31. PubMed ID: 24221504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to enzyme replacement therapy: 4-sulfatase epitope reactivity of plasma antibodies from MPS VI cats.
    Turner CT; Hopwood JJ; Bond CS; Brooks DA
    Mol Genet Metab; 1999 Jul; 67(3):194-205. PubMed ID: 10381327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.